Aspira Pathlab & Diagnostics Ltd — Insider Trading, 25-09-2025: Insider Trading / SAST

Aspira Pathlab & Diagnostics has announced the closure of its trading window for Designated Persons and their immediate relatives, effective October 1, 2025. This closure will remain until 48 hours after the declaration of the financial results for the half-year. This standard procedure precedes key financial disclosures, helping to prevent insider trading. The company will announce the board meeting date for these results in due course, ensuring fair information access for all investors.